Efficient Lymphocyte Migration Across High Endothelial Venules of Mouse Peyer’s Patches Requires Overlapping Expression of L-Selectin and b7 Integrin1 Douglas A. Steeber,2* Mimi L. K. Tang,* Xiu-Qin Zhang,* Werner Mu¨ller,† Norbert Wagner,† and Thomas F. Tedder* Lymphocyte migration into lymphoid organs is regulated by adhesion molecules including L-selectin and the b7 integrins. Lselectin and a4b7 are predominantly hypothesized to direct the selective migration of lymphocytes to peripheral lymph nodes and the gut-associated lymphoid tissues, respectively. To further characterize interactions between L-selectin and b7 integrins during lymphocyte recirculation, mice deficient in both receptors (L-selectin/b7 integrin2/2) were generated. The simultaneous loss of L-selectin and b7 integrin expression prevented the majority of lymphocytes (>95% inhibition) from attaching to high endothelial venules (HEV) of Peyer’s patches and other lymphoid tissues during in vitro binding assays. Moreover, the inability to bind HEV eliminated the vast majority of L-selectin/b7 integrin2/2 lymphocyte migration into Peyer’s patches during short-term and long-term in vivo migration assays (>99% inhibition, p < 0.01). The lack of lymphocyte migration into Peyer’s patches correlated directly with the dramatically reduced size and cellularity (99% reduced) of this tissue in L-selectin/b7 integrin2/2 mice. High numbers of injected L-selectin/b7 integrin2/2 lymphocytes remaining in the blood of wild-type mice correlated with markedly increased numbers of circulating lymphocytes in L-selectin/b7 integrin2/2 mice. Loss of either L-selectin or the b7 integrins alone resulted in significant but incomplete inhibition of Peyer’s patch migration. Collectively, the phenotype of L-selectin/b7 integrin2/2 mice demonstrates that these two receptors primarily interact along the same adhesion pathway that is required for the vast majority of lymphocyte migration into Peyer’s patches. The Journal of Immunology, 1998, 161: 6638 – 6647.
T
he continuous migration of lymphocytes to peripheral and mucosal lymphoid tissues is largely mediated by lymphocyte cell surface receptors binding to their ligands expressed on specialized postcapillary venules termed high endothelial venules (HEV)3 (1– 4). Lymphocyte/HEV interactions in peripheral lymph nodes (PLNs) are predominantly regulated by L-selectin (CD62L), the constitutively expressed leukocyte adhesion molecule identified by the MEL-14 mAb in mice (5, 6). Early studies suggested that L-selectin primarily mediates lymphocyte attachment to HEV of PLNs and mesenteric lymph nodes (MLNs), while migration to Peyer’s patch HEV is primarily controlled by the integrin a4b7 (5, 7–11). Lymphocyte attachment to Peyer’s patch HEV during in vitro assays is specifically and completely blocked by Abs against a4 or b7 integrin chains (12). However, *Department of Immunology, Duke University Medical Center, Durham, NC 27710; and †Institute for Genetics, University of Cologne, Cologne, Germany Received for publication June 12, 1998. Accepted for publication August 28, 1998. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. 1 This work was supported by National Institutes of Health Grants Al-26872, CA54464, and HL-50985. M.L.K.T. was supported by a President’s Grant in Aid Award from the American Academy of Asthma, Allergy, and Immunology. W.M. and N.W. were supported by a grant from the Deutsche Forschungsgemeinschaft (WA1127/1–1). 2 Address correspondence and reprint requests to Dr. Douglas A. Steeber, Department of Immunology, Box 3010, Duke University Medical Center, Durham, NC 27710. E-mail address:
[email protected] 3 Abbreviations used in this paper: HEV, high endothelial venule; PLN, peripheral lymph node; MLN, mesenteric lymph node; MAdCAM-1, mucosal addressin cell adhesion molecule-1; L-selectin2/2, L-selectin-deficient; b7 integrin2/2, b7 integrindeficient; L-selectin/b7 integrin2/2, L-selectin/b7 integrin-deficient; PE, phycoerythrin; MFI, mean fluorescence intensity; Ri, the ratio of calcein-labeled test cells to PKH26-labeled internal control cells injected into mice for migration assays; Ro, the ratio of calcein-labeled test cells to PKH26-labeled internal control cells within each tissue after migration assays.
Copyright © 1998 by The American Association of Immunologists
lymphocyte migration into mouse Peyer’s patches is partially inhibited by Fab of the MEL-14 mAb (13), and mouse Peyer’s patch HEV express low but functional levels of L-selectin carbohydrate ligands (14). The generation of L-selectin-deficient (L-selectin2/2) mice confirmed that L-selectin significantly influences lymphocyte migration into Peyer’s patches and MLNs (6). This has been further supported by intravital microscopic analysis of isolated Peyer’s patches demonstrating that both L-selectin, and to a lesser degree, a4b7 integrins participate in the initial interaction between lymphocytes and HEV as well as in subsequent rolling (15, 16). Consistent with this, a4b7 and a4b1 integrins can each mediate rolling and firm adhesion of lymphocytes during in vitro assays (17–19). L-selectin2/2 mice have a significant reduction (70 –90%) in the number of resident lymphocytes within PLNs, but are viable, have no developmental defects, and do not succumb to multifocal infections (6, 20, 21). Lymphocytes from L-selectin2/2 mice are completely deficient in their ability to attach to PLN HEV during in vitro binding assays and are unable to migrate across HEV of resting or responsive PLNs in normal mice during short-term (1 h) or long-term (48 h) in vivo migration experiments (6, 20 –22). Migration of L-selectin2/2 lymphocytes into Peyer’s patches and MLNs is also dramatically reduced in short-term migration assays, but this deficit largely recovers during long-term assays (6, 22). The ability of L-selectin2/2 lymphocytes to reconstitute Peyer’s patches to near wild-type levels, and MLNs to a lesser extent, in long-term migration assays suggests that either a4b7 mediates a low level of L-selectin-independent cell capture/entry from the blood or alternatively that adhesion molecules other than a4b7 substitute for L-selectin in these tissues. L-selectin2/2 mice also demonstrate decreased leukocyte rolling at sites of inflammation, 0022-1767/98/$02.00
The Journal of Immunology decreased leukocyte recruitment into an inflamed peritoneum, decreased delayed-type hypersensitivity responses, delayed rejection of allogeneic skin transplants, and resistance to LPS-induced septic shock, but have augmented humoral and cellular immune responses (6, 23–27). Lymphocyte migration into lymphoid tissues is also influenced by the b7 integrins: the b7 chain associates with two a-chains to generate a4b7 and aEb7 (7, 12, 28, 29). aEb7 is primarily expressed on intraepithelial lymphocytes and lymphocytes migrating to the mucosa (30 –33). By contrast, the majority of mouse lymphocytes express a4b7, which interacts with the mucosal addressin cell adhesion molecule-1 (MAdCAM-1) to mediate Peyer’s patch and MLN migration (27, 34 –36). MAdCAM-1 is expressed on HEV located within Peyer’s patches and MLN, on vessels within the lamina propria, and on follicular dendritic cells within Peyer’s patches and chronically inflamed PLN and spleen (37–39). b7 integrin-deficient (b7 integrin2/2) mice are healthy, viable, and develop normally (16). These mice have dramatically hypocellular Peyer’s patches that contain only rudimentary follicles, and have lamina propria and intraepithelial lymphocyte numbers that are significantly reduced. Migration of b7 integrin2/2 lymphocytes into Peyer’s patches is severely reduced during short-term in vivo assays, while lymphocyte migration into MLNs is diminished and migration into PLNs is normal (16). Studies using function-blocking mAbs have demonstrated that L-selectin and a4b7 initiate lymphocyte interactions with Peyer’s patch HEV, and L-selectin and a4b7 both participate in rolling during acute migration assays in situ (15). Furthermore, a4b7 dramatically reduces lymphocyte rolling velocities, an apparent requirement for LFA-1 engagement. In additional studies, L-selectin was necessary for 80 –90% of lymphocyte rolling in Peyer’s patch HEVs of wild-type and b7 integrin2/2 mice, while b7 integrins were required for adhesion and emigration during acute migration assays in situ (16, 40). Furthermore, leukocyte rolling on Peyer’s patch HEV occurs at different characteristic velocities with slow rolling predominating in L-selectin2/2 mice and fast rolling characterizing b7 integrin2/2 mice (40). Therefore, both L-selectin and the b7 integrins serve major roles in lymphocyte migration to gut-associated lymphoid tissues. A dual migratory specificity for Peyer’s patches and MLNs involving L-selectin and a4b7 integrins establishes a framework for understanding lymphocyte migration into these tissues. Because most circulating lymphocytes express both L-selectin and b7 integrins (27, 41), a4b7 could mediate selectin-independent cell capture from the blood, thus explaining the ability of L-selectin2/2 lymphocytes to enter Peyer’s patches and MLNs in long-term migration assays. However, it is relevant that significantly more L-selectin2/2 lymphocytes enter the spleen than wild-type lymphocytes during migration assays and that L-selectin2/2 mice have 30 –50% larger spleens than their wild-type littermates. By contrast, Peyer’s patches and MLNs are not increased in size in L-selectin2/2 mice (6, 22). Thus, it remains unresolved as to whether these two molecules account for all lymphocyte migration into Peyer’s patches and MLNs or whether these two receptors have additive functions. Therefore, mice deficient in both L-selectin and b7 integrins (L-selectin/b7 integrin2/2) were generated to further characterize interactions between these adhesion molecules during lymphocyte recirculation. Lymphocyte migration into Peyer’s patches was examined in these studies because the lack of afferent lymphatics precludes lymphocyte entry though other routes (42), which thereby provides an excellent tissue for examining lymphocyte/HEV interactions. The phenotype of L-selectin/b7 integrin2/2 mice demonstrated a requirement for both L-selectin and b7 integrin expression for optimal lymphocyte
6639 migration into Peyer’s patches with lymphocyte migration into this tissue being eliminated in L-selectin/b7 integrin2/2 mice.
Materials and Methods Animals L-selectin2/2 mice were generated as described (6) and backcrossed onto the C57BL/6 background for 7–10 generations. b7 integrin2/2 mice were generated as described (16). Mice lacking both L-selectin and b7 integrins were generated by crossing F1 offspring from crosses of homozygous L-selectin2/2 mice with homozygous b7 integrin2/2 mice as described (43). Cell surface L-selectin or b7 integrin expression by lymphocytes was assessed by two-color fluorescence cytometry. All mice used were 2–3 mo of age and were housed in a specific pathogen-free barrier facility. Control mice were age-matched wild-type mice generated from heterozygous breedings of L-selectin1/2/b7 integrin1/2 mice or were C57BL/6 mice purchased from The Jackson Laboratory (Bar Harbor, ME). Equivalent results were obtained for both groups of control mice, and both groups are referred to subsequently as wild-type mice. All studies and procedures were approved by the Animal Care and Use Committee of Duke University.
Lymphocyte isolation, mAbs, and flow cytometry Blood was aspirated from the retroorbital venous plexus of anesthetized mice. Single-cell suspensions from spleen, PLN (bilateral axillary and inguinal nodes were pooled), MLN (superior mesenteric cords were pooled), and Peyer’s patches were prepared as described (22) and filtered through nylon gauze to remove debris before washing twice in PBS. Erythrocytes in splenocyte suspensions were lysed with Tris-buffered 0.1 M ammonium chloride solution before labeling. Total cell numbers were enumerated using a hemocytometer. For counting blood leukocytes, erythrocytes were lysed with 2% acetic acid. Abs used in these studies included unconjugated, FITC-, or biotin-conjugated mAbs reactive with L-selectin (LAM 1–110, Ref. 44), b7 integrin (M293; PharMingen, San Diego, CA), and a4b7 integrin (DATK-32; American Type Culture Collection, Manassas, VA). Phycoerythrin (PE)conjugated streptavidin was used to reveal biotinylated Ab staining and PE-conjugated goat anti-rat IgG Abs (both from Southern Biotechnology, Birmingham, AL) were used to detect a4b7 integrin labeling. Isotypematched rat IgG Abs (PharMingen) were used as controls. Following staining, blood erythrocytes were lysed with Coulter whole-blood ImmunoLyse kit according to the manufacturer’s instructions (Coulter, Miami, FL). Ten to 30,000 cells with the forward and side light scatter properties of lymphocytes were analyzed on a FACScan flow cytometer (Becton Dickinson, San Jose, CA) with fluorescence intensity shown on a 4-decade log scale. Fluorescence contours are shown as 50% log density plots.
Stamper-Woodruff frozen section assay Lymphocyte binding to PLN, MLN, and Peyer’s patch HEV was performed as previously described (22, 45). Briefly, splenocytes were isolated from wild-type, L-selectin2/2, b7 integrin2/2, and L-selectin/b7 integrin2/2 mice. Following lysis of erythrocytes, cells were washed three times in RPMI 1640 medium (Life Technologies, Gaithersburg, MD) supplemented with 5% FCS and 10 mM HEPES, adjusted to 25 3 106 cells/ ml, and kept on ice until used. Then, 200 ml of the above cell suspension was overlayered onto 12-mm thick frozen sections of PLN, MLN, and Peyer’s patches from wild-type mice. The slides were rotated at 64 rpm for 30 min at 4°C. Cells were then gently dumped off the slides and the slides were placed vertically into 2.4% buffered glutaraldehyde overnight at 4°C. The slides were washed in PBS, counterstained in hematoxylin, and mounted under glass coverslips. For each experiment, splenocytes from each of the four groups of mice were assayed for binding to at least two sections from each tissue.
In vivo lymphocyte migration assays Two-color lymphocyte migration experiments were as described (6, 22). Briefly, single-cell suspensions were prepared from the spleens of donor mice and labeled with calcein-AM (Molecular Probes, Eugene, OR). Splenocytes (5–10 3 107) were incubated in 2 ml of RPMI 1640 medium containing 1 mM calcein on ice for 30 min with gentle mixing every 5 min. Cells were then washed twice in PBS and counted. Internal control wildtype splenocytes were labeled with PKH26 (Sigma, St. Louis, MO). Splenocytes (5 3 107) were resuspended in 1 ml of PKH26 diluent, immediately added to 1 ml of a 3 mM PKH26 dye solution, and incubated for
6640
LYMPHOCYTE MIGRATION IN L-SELECTIN/b7 INTEGRIN-DEFICIENT MICE
FIGURE 1. Characterization of Lselectin/b7 integrin2/2 mice. (A) Blood and (B) spleen lymphocyte expression of L-selectin and b7 integrins was determined by two-color immunofluorescence staining with flow cytometric analysis. b7 integrin expression was visualized using FITC-conjugated M293 mAb. L-selectin expression was visualized using biotinylated LAM1–110 mAb followed by PE-conjugated streptavidin. Quadrant gates indicate negative and positive populations of cells as determined using isotype-matched unreactive control mAbs. Values represent the percentage of gated cells located within the delimited quadrants. C, In vitro binding of splenocytes from wild-type, L-selectin2/2, b7 integrin2/2, and L-selectin/b7 integrin2/2 mice to HEV of Peyer’s patches, MLNs, and PLNs using the Stamper-Woodruff frozen section assay. Values represent the mean (6SEM) number of cells bound/HEV from four independent experiments with a minimum of 175 HEV counted from each group. Results significantly different from wild-type control cells: p, p , 0.05; #, p , 0.01.
2 min at room temperature. For some experiments, b7 integrin2/2 splenocytes were used as an internal control. Labeling was stopped by the addition of 2 ml of FCS. Cell suspensions were washed twice with PBS and counted. Equal numbers (2 3 107) of calcein-labeled and PKH26-labeled cells were mixed, pelleted, and resuspended in a total volume of 400 ml of PBS for injection into the lateral tail veins of individual wild-type mice. An aliquot of the injected cell mixture was analyzed by flow cytometry to calculate the injected ratio of calcein- to PKH26-labeled cells (Ri). After either 1 or 48 h of migration, single-cell suspensions of tissues and blood were prepared, and the percentage of calcein- and PKH26-labeled cells was determined by flow cytometric analysis. Two to 5000 PKH26-labeled cells were collected for each sample. The ratio of calcein-/PKH26-labeled cells within tissues or blood (Ro) was calculated, and results were expressed as the ratio of Ro/Ri in each tissue, as described (6, 22). The total number of calcein- or PKH26-labeled cells recovered from individual lymphoid tissues or blood was determined by multiplying the total cell counts for individual tissues by the frequency of labeled cells.
Statistical Analysis All data are shown as mean values 6 SEM. Comparisons between groups were conducted using the Student’s t test.
Results
Generation of L-selectin/b7 integrin2/2 mice L-selectin2/2 and b7 integrin2/2 mice were crossed to generate mice homozygous deficient at both loci (L-selectin/b7 integrin2/2)
as described (43). Each group of mice was free from obvious signs of pathology or disease for up to 1 yr of age. Leukocytes from L-selectin/b7 integrin2/2 mice completely lacked cell surface expression of both L-selectin and b7 integrins (Fig. 1, A and B). Both circulating and splenic leukocytes from L-selectin2/2 mice expressed wild-type levels of b7 integrins, while leukocytes from b7 integrin2/2 mice expressed wild-type levels of L-selectin (Table I). Significant differences in the percentage of circulating or splenic leukocytes expressing either L-selectin or b7 integrins were not observed in b7 integrin2/2 or L-selectin2/2 mice, respectively, compared with wild-type mice (Table I). Thus, the loss of one adhesion molecule did not lead to significant changes in expression intensity or frequency of the other adhesion molecule. However, circulating leukocytes expressing both L-selectin and b7 integrins were present at a higher frequency compared with spleen cells in wild-type mice as previously reported (27). L-selectin and b7 integrin loss was confirmed by determining the ability of splenocytes from L-selectin/b7 integrin2/2 mice to bind to HEV of Peyer’s patch, MLN, and PLN during in vitro frozen-section binding assays (45). The loss of both L-selectin and b7 integrin expression resulted in a $95% reduction in lymphocyte binding to HEV of each lymphoid tissue (Fig. 1C). L-selectin loss resulted in an ;30% decrease in splenocyte binding to HEV
The Journal of Immunology
6641
Table I. Expression of L-selectin or b7 integrins by circulating and splenic lymphocytes a Percent of Cells That Are L-Selectin1 or b7 Integrin1 (MFI of Expression)b Tissue
Marker
Wild type
L-selectin2/2
b7 integrin2/2
L-selectin/b72/2
Blood
L-selectin
93 6 1 (387 6 30) 86 6 1 (34 6 2) 88 6 2 (276 6 14) 73 6 1 (29 6 1)
1 6 1* (6 6 1)* 86 6 1 (30 6 2) 2 6 1* (7 6 1)* 77 6 2 (28 6 1)
91 6 1 (372 6 36) 1 6 1* (5 6 1)* 85 6 2 (304 6 31) 3 6 1* (5 6 1)*
1 6 1* (7 6 1)* 1 6 1* (4 6 1}* 2 6 1* (8 6 1)* 2 6 1* (5 6 1)*
b7 integrin Spleen
L-selectin
b7 integrin
a Adhesion molecule expression by circulating and splenic lymphocytes from wild-type and mutant mice was determined by two-color fluorescence cytometry as in Fig. 1. Values represent the mean results (6SEM) obtained from three age-matched mice of each genotype. b MFI, mean fluorescence intensity. Values represent the mean (6SEM) linear fluorescence channel numbers for each labeled population. *, Results were significantly different from wild-type mice, p ,0.001.
of Peyer’s patch, a 75% decrease in binding to MLN HEVs, and a 98% decrease in binding to PLN HEVs. Loss of b7 integrin expression resulted in a 97% and 46% reduction in splenocyte binding to Peyer’s patch and MLN HEVs, respectively, without a significant loss in binding to PLN HEVs (Fig. 1C). Therefore, L-selectin and b7 integrins collectively mediate the vast majority of lymphocyte binding to HEV under these in vitro conditions. Peyer’s patch development in L-selectin/b7 integrin2/2 mice The loss of both L-selectin and b7 integrins severely affected the distribution of lymphocytes within Peyer’s patches from 2-mo-old L-selectin/b7 integrin2/2 mice. Most Peyer’s patches from L-selectin/b7 integrin2/2 mice were virtually undetectable macroscopically with an average of 3.5 6 0.4 (range 2–5; p , 0.001 vs wild-type; n 5 12) Peyer’s patches being identified in each mouse. The most easily identified Peyer’s patches showed no protrusion from the gut wall and were nearly translucent in color. This was
consistent with a significant reduction in numbers of lymphocytes present in histologic sections of these Peyer’s patches (Fig. 2). However, despite the small size and significant reduction in cellularity of Peyer’s patches from L-selectin/b7 integrin2/2 mice, rudimentary follicles were still observed (Fig. 2). Microscopic examination of serial sections across the entire gut revealed an equal number of Peyer’s patches in both wild-type and L-selectin/b7 integrin2/2 mice, as described for b7 integrin2/2 mice (16). Macroscopic examination revealed equal numbers (range of 6 –12) of readily detectable Peyer’s patches that were microscopically similar protruding from the gut wall in both wild-type and L-selectin2/2 mice (Fig. 2). Normal numbers of Peyer’s patches were visually identified and harvested from b7 integrin2/2 mice (7.7 6 0.6 per mouse, range 6 –10, n 5 6). However, Peyer’s patches of b7 integrin2/2 mice were markedly reduced in size and protruded only minimally from the gut wall, making them macroscopically less apparent (Fig. 2, and Ref. 16). Thus, the combined loss of
FIGURE 2. Histologic structure of Peyer’s patches from wild-type, L-selectin2/2, b7 integrin2/2, and L-selectin/b7 integrin2/2 mice. Formalin-fixed tissues were embedded in paraffin and subsequent sections were stained in hematoxylin and eosin (magnification, 368). These results are representative of the tissues obtained from at least three mice of each genotype.
LYMPHOCYTE MIGRATION IN L-SELECTIN/b7 INTEGRIN-DEFICIENT MICE
6642
Table II. Numbers of leukocytes in lymphoid tissues of L-selectin/b7 integrin2/2 mice a Mononuclear Cell Numbers (3 1026) Tissue
Wild type
L-selectin2/2
b7 integrin2/2
L-selectin/b72/2
Peyer’s Patches MLN PLNb Bloodc Lymphocytes Monocytes Neutrophils Eosinophils Spleen
3.0 6 0.5 13.0 6 1.1 10.3 6 2.4 4.8 6 0.6 3.8 6 0.5 0.2 6 0.1 0.7 6 0.1 0.1 6 0.1 68.3 6 9.5
2.2 6 0.2 6.7 6 1.0* 0.5 6 0.1* 5.0 6 0.8 3.7 6 0.6 0.4 6 0.1* 0.8 6 0.2 0.1 6 0.1 109.1 6 11.3*
0.3 6 0.1*† 14.8 6 1.3† 11.4 6 0.9† 7.5 6 1.0* 5.7 6 0.8* 0.3 6 0.1 1.2 6 0.1* 0.3 6 0.1* 89.7 6 8.6
0.03 6 0.01*†‡ 1.0 6 0.1*†‡ 0.8 6 0.2*‡ 12.4 6 1.1*†‡ 9.5 6 0.9*†‡ 0.9 6 0.1*†‡ 1.6 6 0.2*† 0.4 6 0.1*† 162.3 6 16.5*†‡
a
Values represent the mean results (6SEM) obtained from 6 to 30 age-matched mice of each genotype. Values represent results from pooled inguinal and axillary lymph node pairs. Total cells are per ml of blood. Differential leukocyte counts were performed on blood smear preparations following Wright-Giemsa staining. *, Results were significantly different from wild-type mice; p , 0.05. †, Significantly different from L-selectin2/2 mice; p , 0.05. ‡, Significantly different from b7 integrin2/2 mice; p , 0.05. b c
L-selectin and b7 integrin expression had a major effect on Peyer’s patch cellularity, but not its overall gross architecture. Tissue distribution of lymphocytes in L-selectin/b7 integrin2/2 mice The numbers of lymphocytes within Peyer’s patches of L-selectin/b7 integrin2/2 mice were reduced significantly beyond the decreases resulting from the loss of either L-selectin or b7 integrin expression alone. Specifically, Peyer’s patches of L-selectin/b7 integrin2/2 mice were reduced in cellularity by .99% in comparison with wild-type mice (Table II). This may be a slight underestimate of the effect of L-selectin/b7 integrin loss because the small size of Peyer’s patches from these mice resulted in a higher recovery of intraepithelial lymphocytes that surrounded the Peyer’s patches and contaminated the Peyer’s patch cell populations to varying degrees (data not shown). However, as stated above, the smallest of the Peyer’s patches from the L-selectin/b7 integrin2/2 mice were not identified macroscopically and thus were not harvested or included in the cell counts. Peyer’s patches in b7 integrin2/2 mice were reduced by ;90% as previously described (16), which was significantly different from wild-type or L-selectin2/2 mice. These results indicate that L-selectin and b7 integrins account for the vast majority of lymphocyte migration into Peyer’s patches. Lymphocyte numbers within MLNs of L-selectin/b7 integrin2/2 mice were reduced by 92% relative to wild-type mice (Table II, and Ref. 43). L-selectin2/2 mice had an ;45% reduction, while b7 integrin2/2 and wild-type mice had similar numbers of MLN lymphocytes. By contrast, the loss of L-selectin expression resulted in a 95% decrease in PLN lymphocytes, but the number of resident lymphocytes within PLNs of L-selectin2/2 mice tended to be increased with the additional loss of b7 integrin expression (Table II). b7 integrin loss also resulted in a 10% increase in PLN cellularity. These results are consistent with overlapping functions for L-selectin and b7 integrins during lymphocyte entry into MLNs, but point out that b7 integrin expression does not contribute substantially to lymphocyte migration into PLNs. Circulating leukocyte numbers were markedly increased in Lselectin/b7 integrin2/2 mice relative to wild-type mice (by 260%, Table II). By contrast, circulating leukocyte numbers were not significantly different between wild-type and L-selectin2/2 mice and were only slightly elevated in b7 integrin2/2 mice. Increased lymphocyte numbers accounted for the vast majority of the increase in circulating leukocytes in L-selectin/b7 integrin2/2 mice. Smaller,
yet significant, relative increases in numbers of circulating neutrophils, monocytes, and eosinophils were also observed in these mice compared with wild-type controls. L-selectin2/2 mice had significantly increased numbers of circulating monocytes (;130% increase) compared with wild-type controls as previously described (22). Mice deficient in b7 integrins alone had slightly increased numbers of circulating neutrophils, lymphocytes, and eosinophils relative to wild-type mice (Table II). The loss of L-selectin resulted in an ;60% increase in spleen lymphocytes, which was further increased by 49% with the additional loss of b7 integrin expression (Table II). There was a trend toward increased spleen cellularity with the loss of b7 integrin expression, although this was a variable finding. Therefore, the combined loss of L-selectin and the b7 integrins had an additive effect on the number of circulating leukocytes and the number of lymphocytes that accumulated within the spleen. Migration of L-selectin/b7 integrin2/2 lymphocytes into lymphoid tissues The extent that L-selectin and the b7 integrins regulate lymphocyte entry into lymphoid tissues was assessed in short-term (1 h) in vivo migration assays. Splenocytes from wild-type, L-selectin2/2, b7 integrin2/2, and L-selectin/b7 integrin2/2 mice were labeled with calcein, mixed with an equal number of PKH26-labeled wild-type splenocytes (internal control), and injected i.v. into wild-type mice. The frequency of labeled lymphocytes within tissues was determined after 1 h. Differences in migration patterns were assessed by comparing the ratio of calcein-labeled test cells to PKH26-labeled internal control cells present within each tissue (Ro) with the ratio of calcein-labeled test cells to PKH26-labeled control cells that were injected (Ri). Splenocytes were used for these studies because they represent mixed populations of T and B cells, contain both naive and memory cell populations, and have the most heterogeneous distribution of L-selectin and b7 integrin expression (27). Nonetheless, the distribution of lymphocyte populations present within the spleens of 2-mo-old L-selectin/b7 integrin2/2 mice was not dramatically different from that of wildtype mice (D.A.S., X.-Q.Z., N.W., and T.F.T., manuscript in preparation), b7 integrin2/2 mice (16) or L-selectin2/2 mice (22). The migration of L-selectin/b7 integrin2/2 lymphocytes into Peyer’s patches was dramatically decreased compared with wildtype (99% decrease, p , 0.001), L-selectin2/2 (96% decrease, p , 0.001), or b7 integrin2/2 lymphocytes (85% decrease, p , 0.01) (Fig. 3). Similarly, the migration of double-deficient lymphocytes
The Journal of Immunology
FIGURE 3. Short-term in vivo migration of splenocytes from wild-type, L-selectin2/2, b7 integrin2/2, and L-selectin/b7 integrin2/2 mice. Calceinlabeled splenocytes from test or wild-type mice were mixed with an equal number of internal control PKH26-labeled wild-type splenocytes and injected into the tail veins of wild-type mice. Lymphocytes were isolated from the indicated tissues after 1 h and analyzed by fluorescence cytometry. The ratio of calcein-labeled test cells to PKH26-labeled internal control cells within each tissue (Ro) was normalized by dividing with the injected ratio of calcein-labeled test cells to PKH26-labeled control cells (Ri) to generate Ro/Ri ratios as described in Materials and Methods. Values represent the mean (6SEM) Ro/Ri ratios obtained in three to six independent experiments. p, Differences between test and wild-type splenocytes were significant, p , 0.01. #, Significantly different from all other genotypes, p , 0.05.
into MLNs was significantly decreased compared with wild-type (by 99%, p , 0.001), L-selectin2/2 (by 77%, p , 0.01), or b7 integrin2/2 (by 98%, p , 0.001) lymphocytes (43). The combined loss of L-selectin and b7 integrin expression resulted in a reduction of lymphocyte migration to PLNs similar to the decrease observed for L-selectin2/2 lymphocytes (Fig. 3). The increase in L-selectin/b7 integrin2/2 lymphocyte migration to the spleen was also similar to that seen for L-selectin2/2 lymphocytes (Fig. 3). The combined loss of both L-selectin and b7 integrin expression increased the number of lymphocytes remaining in the blood after 1 h by 25% ( p , 0.01) compared with wild-type lymphocytes. Therefore, the L-selectin/b7 integrin2/2 deficiency significantly reduced lymphocyte migration into Peyer’s patches and MLNs beyond the level seen in the single-deficient lymphocytes, while enhancing blood and spleen localization. To more precisely quantify and verify that L-selectin/b7 integrin2/2 lymphocyte migration was different from that of b7 integrin2/2 lymphocytes, splenocytes from L-selectin/b7 integrin2/2 mice were labeled with calcein and mixed with an equal number of internal control PKH26-labeled b7 integrin2/2 splenocytes. One hour after i.v. injection into wild-type mice, there was a 96% reduction in migration of L-selectin/b7 integrin2/2 lymphocytes into Peyer’s patches relative to the migration of b7 integrin2/2 lymphocytes ( p , 0.01, Fig. 4). There was also a 97% decrease in L-selectin/b7 integrin2/2 lymphocyte migration into MLNs and a 98% reduction of migration into PLNs as compared with b7 integrin2/2 lymphocytes ( p , 0.01). Therefore, L-selectin is necessary for the efficient migration of wild-type and b7 integrin2/2 lymphocytes into Peyer’s patches and MLN and the combined effect of these deficiencies is more than additive.
6643
FIGURE 4. L-selectin expression is required for the migration of b7 integrin2/2 splenocytes into Peyer’s patches in vivo. Calcein-labeled splenocytes from b7 integrin2/2 or L-selectin/b7 integrin2/2 mice were mixed with an equal number of internal control PKH26-labeled b7 integrin2/2 splenocytes and injected into the tail veins of wild-type mice. After 1 h, lymphocytes were isolated from the indicated tissues and analyzed by fluorescence cytometry as described in Fig. 3. Values represent the mean (6SEM) Ro/Ri ratios obtained in three independent experiments. p, Differences between b7 integrin2/2 and L-selectin/b7 integrin2/2 splenocytes were significant; p , 0.01.
Accumulation of L-selectin/b7 integrin2/2 lymphocytes in lymphoid tissues To assess how L-selectin and b7 integrin loss affected the accumulation of recirculating lymphocytes within tissues after the cells had the opportunity to reach equilibrium, in vivo migration assays were conducted as described above except lymphocyte localization within tissues was assessed at 48 h. Lymphocytes deficient in both L-selectin and b7 integrin expression were excluded from entering Peyer’s patches (.99% decrease, p , 0.001) relative to wild-type lymphocytes (Fig. 5). Furthermore, lymphocyte localization within MLNs (.99% decrease, p , 0.001) and PLNs (98% decrease, p , 0.001) was also significantly affected when compared with wildtype lymphocytes (Fig. 5). By contrast, b7 integrin2/2 lymphocytes showed a 94% decrease in Peyer’s patch migration and a modest 34% decrease in MLN migration when compared with
FIGURE 5. Long-term migration of splenocytes from wild-type, L-selectin2/2, b7 integrin2/2, and L-selectin/b7 integrin2/2 mice. Calceinlabeled splenocytes from test or wild-type mice were mixed with an equal number of internal control PKH26-labeled wild-type splenocytes and injected into the tail veins of wild-type mice. After 48 h, lymphocytes were isolated from the indicated tissues and analyzed by fluorescence cytometry as described in Fig. 3. Values represent the mean (6SEM) Ro/Ri ratios obtained in three independent experiments. p, Differences between test and wild-type splenocytes were significant, p , 0.01. #, Significantly different from all other genotypes, p , 0.05.
LYMPHOCYTE MIGRATION IN L-SELECTIN/b7 INTEGRIN-DEFICIENT MICE
6644
Table III. Number of fluorochrome-labeled splenocytes migrating into lymphoid tissues a Genotype of Injected Lymphocytes Tissue
1h Peyer’s patch MLN PLNb Bloodc Spleen 48 h Peyer’s patch MLN PLNb Bloodc Spleen
Wild type
L-selectin2/2
b7 integrin2/2
L-selectin/b72/2
5,770 6 726 51,900 6 4,670 41,100 6 5,830 152,000 6 23,500 1,080,000 6 123,000
2,990 6 1,270 2,810 6 877* 1,080 6 299* 177,000 6 53,400 1,230,000 6 302,000
660 6 152*† 45,500 6 3,130† 49,500 6 8,750† 157,000 6 29,000 965,000 6 123,000
45 6 12*†‡ 956 6 405*†‡ 2,640 6 1,170*‡ 179,000 6 78,800 2,160,000 6 260,000*†‡
23,400 6 5,460 156,000 6 23,200 153,000 6 37,300 98,100 6 18,000 1,090,000 6 159,000
18,900 6 5,680 10,300 6 868* 1,210 6 469* 106,000 6 20,400 1,370,000 6 140,000
1,640 6 344*† 98,500 6 7,630† 170,000 6 32,500† 83,500 6 27,000 994,000 6 87,100†
50 6 28*†‡ 1,550 6 659*†‡ 2,330 6 563*‡ 149,000 6 5,180†‡ 2,990,000 6 503,000*†‡
a Numbers of calcein- or PKH26-labeled splenocytes within the indicated tissues or blood were calculated from the in vivo migration assays described in Figs. 3 and 5. Absolute numbers of migrated cells were calculated as described in Materials and Methods. Values represent the mean results (6SEM) obtained from 3 to 13 age-matched mice of each genotype. b Values represent results from pooled inguinal and axillary lymph node pairs. c Number of cells are per ml of blood. * Results obtained for test mice were significantly different from wild-type mice; p , 0.05. †, Significantly different from L-selectin2/2 mice; p , 0.05. ‡, Significantly different from b7 integrin2/2 mice; p , 0.05.
wild-type splenocytes (Fig. 5). The number of circulating L-selectin/b7 integrin2/2 lymphocytes remained increased at 48 h (by ;60%, p , 0.01) relative to splenocytes from all other groups of mice (Fig. 5). The migration of L-selectin/b7 integrin2/2 lymphocytes into the spleen was increased by twofold relative to wild-type lymphocytes ( p , 0.001) and tended to be increased slightly relative to L-selectin2/2 lymphocytes (Fig. 5). These results show that the L-selectin/b7 integrin deficiency eliminated the vast majority of lymphocyte recirculation through Peyer’s patches, MLNs, and PLNs. Numbers of lymphocytes migrating into lymphoid tissues Conclusions similar to those discussed above were obtained when the numbers of splenocytes that migrated into tissues at 1 and 48 h were determined (Table III). Within Peyer’s patches, L-selectin/b7 integrin2/2 lymphocyte migration was ,1% of wild-type levels at 1 h and ;0.2% at 48 h. Within MLNs, L-selectin/b7 integrin2/2 lymphocyte migration was ,2% of wild-type levels at 1 h and ,1% at 48 h. Similarly, L-selectin/b7 integrin2/2 lymphocyte migration into PLNs was ;6% of wild-type levels at 1 h and ;1.5% at 48 h. These results indicate that the L-selectin/b7 integrin deficiency affects the majority of splenocyte migration including both naive and memory subpopulations. Two additional observations were of interest. First, despite the L-selectin/b7 integrin deficiency a very small number of lymphocytes were nonetheless able to enter Peyer’s patches and MLNs at 1 h (Table III). These emigrant cells were lymphocytes, although their identity or whether they represented lymphocytes present within the vasculature of the harvested tissues was not assessed. However, the number of labeled L-selectin/b7 integrin2/2 lymphocytes within Peyer’s patches and MLNs did not increase over the subsequent 48 h. This is in stark contrast to results obtained using splenocytes of wild-type or single-deficient mice. Specifically, migration of wild-type lymphocytes to Peyer’s patches and MLNs at 48 h increased by four- and threefold, respectively, relative to 1 h numbers ( p , 0.001, Table III). Similar increases in numbers of L-selectin2/2 lymphocytes migrating to Peyer’s patches and MLNs (6.3- and 3.7-fold, respectively, p , 0.05) were observed over this time period. b7 integrin2/2 lymphocytes showed significant but smaller increases in numbers of migrating lymphocytes over the 48-h time period (;2.3-fold, p , 0.02) relative to wild-type or L-selectin2/2 cells.
Therefore, in contrast to L-selectin/b7 integrin2/2 lymphocytes, these results indicate that wild-type and single-deficient lymphocytes accumulate within these tissues. A second interesting result was that the number of L-selectin/b7 integrin2/2 lymphocytes entering PLNs was two- to threefold greater than the number of L-selectin2/2 lymphocytes at both 1 and 48 h (Table III). This observation appears valid because the number of resident lymphocytes within PLNs of L-selectin/b7 integrin2/2 mice tended to be greater than in L-selectin2/2 littermates (Table II). Although the numbers of L-selectin2/2 or Lselectin/b7 integrin2/2 lymphocytes migrating into PLNs did not increase from 1 to 48 h, numbers of wild-type or b7 integrin2/2 cells increased ;3.5-fold (Table III, p , 0.01). Within the circulation, the number of wild-type or single-deficient lymphocytes decreased by 40 –50% over the 48-h time period (Table III). By contrast, the number of circulating L-selectin/b7 integrin2/2 lymphocytes only decreased a modest 20% from 1 to 48 h. These results further support the observations that lymphocytes lacking L-selectin and b7 integrin expression are unable to leave the circulation and enter lymphoid tissues such as Peyer’s patches, PLNs, and MLNs and are consistent with the significantly elevated numbers of circulating lymphocytes observed in L-selectin/b7 integrin2/2 mice (Table II). L-selectin and b7 integrin expression by resident Peyer’s patch lymphocytes Whether the loss of L-selectin or b7 integrin expression skewed Peyer’s patch lymphocyte expression of b7 integrins or L-selectin, respectively, was assessed in adhesion molecule-deficient mice. As observed for circulating lymphocytes (Fig. 1A), L-selectin loss did not affect the level of b7 integrin expression by lymphocytes within Peyer’s patches (Fig. 6). Most lymphocytes within Peyer’s patches of wild-type (94 6 1% positive, n 5 4) and L-selectin2/2 (92 6 1%, n 5 4) mice expressed a4b7 at comparable intensities. By contrast, the frequency of L-selectin expressing lymphocytes in b7 integrin2/2 mice (45 6 5%, n 5 4) was significantly lower than in wild-type mice (75 6 4%, n 5 3, p , 0.002), although Lselectin was expressed at similar intensities by most L-selectinbearing lymphocytes (Fig. 6). The lower frequency of L-selectin expressing lymphocytes in Peyer’s patches of b7 integrin2/2 mice compared with blood lymphocytes (Fig. 1) is likely to reflect the
The Journal of Immunology
FIGURE 6. L-selectin or b7 integrin expression by Peyer’s patch lymphocytes of b7-integrin2/2 or L-selectin2/2 mice, respectively. a4b7 integrin (left panel) or L-selectin (right panel) expression was assessed by immunofluorescence staining with flow cytometry analysis. Histograms representing staining of wild-type (heavy lines) and single-deficient (thin lines) lymphocytes are shown. Dotted histograms represent results obtained with isotype-matched control mAbs. These results are representative of those obtained with at least three mice of each genotype.
slower entry of circulating lymphocytes into this tissue in the absence of b7 integrin expression. As a result, the majority of Peyer’s patch lymphocytes in b7 integrin2/2 mice are likely to have been long-term residents within this tissue or may have arisen from in situ proliferation. This alters the lymphocyte subset distribution within Peyer’s patches of b7 integrin2/2 mice compared with wild-type mice, but these changes are relatively minor (D.A.S., X.-Q.Z., N.W., and T.F.T., manuscript in preparation). An additional previously discussed influence on L-selectin expression is that Peyer’s patch preparations from L-selectin/b7 integrin2/2 mice contain some degree of contaminating gut lymphocytes that typically do not express L-selectin.
Discussion In this study, L-selectin and the b7 integrins regulated the vast majority of lymphocyte migration across HEVs of Peyer’s patches, MLNs, and other peripheral lymphoid tissues. The simultaneous genetic loss of both L-selectin and b7 integrin expression prevented the majority of lymphocytes (.95% inhibition) from attaching to HEV of Peyer’s patches during in vitro binding assays (Fig. 1). Moreover, the inability to bind HEV eliminated the vast majority of L-selectin/b7 integrin2/2 lymphocyte migration into Peyer’s patches during short-term in vivo migration assays (.99% inhibition, p , 0.01, Fig. 3, Table III) as well as the long-term localization of lymphocytes in these tissues (.99% inhibition, p , 0.01, Fig. 5, Table III). The lack of lymphocyte migration into Peyer’s patches correlated directly with the dramatically reduced size (Fig. 2) and cellularity (99% reduced) of this tissue in Lselectin/b7 integrin2/2 mice (Table II). In addition, the increased numbers of injected L-selectin/b7 integrin2/2 lymphocytes remaining in the blood of wild-type mice after 48 h (Fig. 5) correlated with the markedly increased numbers of circulating lymphocytes found in L-selectin/b7 integrin2/2 mice (Table II). While loss of either L-selectin or, to a greater extent, the b7 integrins alone resulted in significant inhibition of Peyer’s patch migration, neither produced complete inhibition. Collectively, these results indicate that L-selectin and b7 integrins primarily interact along the same adhesion pathway to mediate the vast majority of lymphocyte migration into Peyer’s patches, although each molecule can function independent of the other, albeit less efficiently. The current study of lymphocyte migration into Peyer’s patches extends prior in situ studies (15, 16, 40) by demonstrating that the combined absence of L-selectin and b7 integrins eliminates the vast majority of lymphocyte migration into mouse Peyer’s patches (Figs. 3 and 5). Because the current studies circumvent the inflam-
6645 matory influences introduced by the invasive surgical procedures necessary to view leukocyte/endothelial interactions in situ (15, 16, 40), it is likely that L-selectin and the b7 integrins are the essential receptors for normal migration during noninflammatory situations. The absence of lymphocyte migration into Peyer’s patches even after 48 h suggests that other adhesive mechanisms are unlikely to compensate significantly for the loss of both Lselectin and b7 integrins during migration into reactive Peyer’s patches because other adhesion molecules are unable to compensate for L-selectin loss during lymphocyte entry into reactive PLNs across HEVs (22). Therefore, a remaining issue is the identity of the adhesion molecules that facilitate lymphocyte migration into Peyer’s patches in the absence of L-selectin or b7 integrin expression. P-selectin has recently been shown to support a low level of leukocyte rolling along Peyer’s patch venules from L-selectin/b7 integrin2/2 mice following exteriorization (40). It has also been postulated that P-selectin facilitates the entry of lymphocytes into lymphoid tissues across HEVs by the formation of lymphocyteplatelet aggregates (46, 47). However, because lymphocytes do not migrate across HEVs of resting or activated PLNs in the absence of L-selectin expression (22) and circulating lymphocyte-platelet aggregates are not encountered under normal physiologic conditions, this mechanism may only contribute modestly to lymphocyte entry into lymphoid tissues. Therefore, it is likely that a4b7 integrins mediate lymphocyte capture and rolling on Peyer’s patch HEV in the absence of L-selectin expression, albeit at much lower levels of efficiency than the combination of L-selectin and b7 integrins. Previous studies have documented a role for LFA-1 during lymphocyte migration into lymphoid tissues (48), and L-selectin and ICAM-1 function cooperatively to mediate leukocyte rolling at sites of inflammation (26). Consistent with this, migration of b7 integrin2/2 lymphocytes into Peyer’s patches is further significantly reduced with the additional loss of ICAM-1 expression (D.A.S., X.-Q.Z., and T.F.T., unpublished observations). Therefore, it is likely that these molecules retard lymphocyte rolling velocities sufficiently to permit the formation of firm adhesive interactions that proceed lymphocyte migration into Peyer’s patches in the absence of b7 integrin expression. However, in the absence of L-selectin and b7 integrin expression, these alternative adhesive mechanisms are inadequate to mediate lymphocyte migration into Peyer’s patches. T cells migrate into Peyer’s patches and all other lymphoid tissues at a faster tempo than B cells, in part, due to their expression of 50 –100% higher levels of L-selectin compared with B cells (27). Although B cells express a4b7 integrins at twofold higher levels than T cells, more T cells still migrate into Peyer’s patches. In the absence of L-selectin expression, the vast majority of PLN lymphocytes (which are predominantly T cells) are unable to enter Peyer’s patches (22) despite the fact that the majority of these cells express a4b7 integrins (27). In fact, even in the absence of Lselectin expression, spleen T cells migrate into Peyer’s patches at a fivefold higher rate than spleen B cells (27). However, b7 integrin loss appeared to have a more significant effect on splenocyte/ Peyer’s patch HEV interactions than the loss of L-selectin in the current studies (Figs. 3 and 5). This apparently contradictory finding points out a need for further examination of the differential roles for L-selectin and b7 integrins in short-term T and B cell subset migration. For example, a loss of b7 integrin expression by B cells in combination with their lower levels of L-selectin expression may significantly diminish or preclude their entry into Peyer’s patches. Although many of the effects of adhesion receptor loss described in the current study were quite large and thereby
6646
LYMPHOCYTE MIGRATION IN L-SELECTIN/b7 INTEGRIN-DEFICIENT MICE
were likely to involve most or all lymphocyte subsets, heterogeneity of L-selectin and b7 integrin expression on some minor lymphocyte subsets may be of substantial importance in directing their trafficking to selective tissues (49). Nonetheless, the results discussed above demonstrate that adhesion molecule requirements during migration may not be generally equivalent between lymphocytes isolated from different lymphoid tissues. In addition to facilitating lymphocyte/HEV interactions, we have postulated previously that the b7 integrins retain lymphocytes within Peyer’s patches subsequent to their entry across HEV, particularly B cells (27). The current studies validate this hypothesis. The entry of L-selectin2/2 and b7 integrin2/2 lymphocytes into Peyer’s patches at 1 h is inhibited by 48 –70% and 89% relative to lymphocytes from wild-type mice, respectively (Table III and Ref. 27). However, by 48 h the number of emigrant L-selectin2/2 lymphocytes within Peyer’s patches is similar to that of wild-type lymphocytes (Table III). Peyer’s patches in L-selectin2/2 and wild-type mice are also similar in cellularity (6, 22). Therefore, although the loss of L-selectin greatly reduces the tempo of lymphocyte migration into Peyer’s patches, emigrant L-selectin2/2 lymphocytes can populate this tissue to near wild-type levels by 48 h. By contrast, the number of newly emigrated b7 integrin2/2 lymphocytes within Peyer’s patches by 48 h is 93% below that of wild-type lymphocytes (Table III). Similarly, the cellularity of Peyer’s patches in b7 integrin2/2 mice is reduced by 90% (Table II and Ref. 16). Therefore, the bulk of lymphocytes that enter Peyer’s patches are not retained in the absence of b7 integrin expression. This is perhaps consistent with the recent observation that MAdCAM-1 is expressed at sites within lymphoid tissues in addition to its display by HEV (37). L-selectin and a4b7 have been predominantly hypothesized to direct the selective migration of lymphocytes to peripheral lymph nodes and the gut, respectively (reviewed in 50). However, this conclusion is based in part on the prediction that lymphocytes selectively recirculating through an organ will preferentially express adhesion receptors for organ-specific endothelial ligands that allowed their entry into that organ. Thus, when lymphocytes exiting a given tissue expressed high or low levels of a particular adhesion molecule, this has been felt to provide strong support for that molecule being either involved or not involved, respectively, in lymphocyte entry into the tissue. However, the current studies demonstrate a variable and heterogeneous pattern of L-selectin expression on Peyer’s patch lymphocytes in b7 integrin2/2 mice (Fig. 6) despite the fact that L-selectin is critically involved in lymphocyte migration into this tissue in the absence of b7 integrin expression (Figs. 3 and 5). Conversely, the majority of PLN lymphocytes express a4b7 (27), although the b7 integrins play no apparent role in lymphocyte migration into PLNs (Figs. 3 and 5). Collectively, these findings force the conclusion that adhesion molecule expression by lymphocytes within or exiting a given tissue is likely to reflect processes or developmental programs ongoing within that tissue rather than emulate the display of adhesion molecules necessary for lymphocyte entry into that tissue. Although it has been well recognized that L-selectin and the b7 integrins play major roles in the migration of lymphocytes into secondary lymphoid tissues it was surprising that the loss of these two adhesion molecules eliminated the vast majority of lymphocyte migration into Peyer’s patches. Although concomitant L-selectin/b7 integrin loss also dramatically inhibited lymphocyte migration into other HEV-bearing lymphoid tissues, PLNs and MLNs retained 7– 8% of their wild-type levels of cellularity (Table II), presumably due to lymphocyte entry through their afferent lymphatics. Therefore, whether the deficiency in Peyer’s patches has deleterious or selective effects on mucosal immunity will be an
important issue to resolve. Moreover, because lymphocyte entry into PLNs, MLNs, and Peyer’s patches represents only a small portion of lymphocyte migration (51), it will be important to assess whether the loss of L-selectin/b7 integrins has additional detrimental effects on lymphocyte migration to other extralymphoid sites of lymphocyte accumulation.
Acknowledgments We thank Dr. Scott Palmer and Ms. Jennifer Sloane for their help in the early stages of these studies.
References 1. Marchesi, V. T., and J. L. Gowans. 1964. The migration of lymphocytes through the endothelium of venules in lymph nodes. Proc. Roy. Soc. Ser. B 159:283. 2. Pabst, R., and R. M. Binns. 1989. Heterogeneity of lymphocyte homing physiology: several mechanisms operate in the control of migration to lymphoid and non-lymphoid organs in vivo. Immunol. Rev. 108:83. 3. Picker, L. J., and E. C. Butcher. 1992. Physiological and molecular mechanisms of lymphocyte homing. Annu. Rev. Immunol. 10:561. 4. Tedder, T. F., D. A. Steeber, A. Chen, and P. Engel. 1995. The selectins: vascular adhesion molecules. FASEB J. 9:866. 5. Gallatin, W. M., I. L. Weissman, and E. C. Butcher. 1983. A cell-surface molecule involved in organ-specific homing of lymphocytes. Nature 304:30. 6. Arbones, M. L., D. C. Ord, K. Ley, H. Radich, C. Maynard-Curry, D. J. Capon, and T. F. Tedder. 1994. Lymphocyte homing and leukocyte rolling and migration are impaired in L-selectin (CD62L) deficient mice. Immunity 1:247. 7. Holzmann, B., B. W. McIntyre, and I. L. Weissman. 1989. Identification of a murine Peyer’s patch-specific lymphocyte homing receptor as an integrin molecule with an a chain homologous to human VLA-4a. Cell 56:37. 8. Geoffroy, J. S., and S. Rosen. 1989. Demonstration that a lectin-like receptor (gp90mel) directly mediates adhesion of lymphocytes to high endothelial venules of lymph nodes. J. Cell Biol. 109:2463. 9. Rosen, S. D., M. S. Singer, Y. A. Yednock, and L. M. Stoolman. 1985. Involvement of sialic acid on endothelial cells in organ-specific lymphocyte recirculation. Science 228:1005. 10. Rosen, S. D., S. I. Chi, D. D. True, M. S. Singer, and T. A. Yednock. 1989. Intravenously injected sialidase inactivates attachment sites for lymphocytes on high endothelial venules. J. Immunol. 142:1895. 11. Watson, S. R., Y. Imai, C. Fennie, J. S. Geoffrey, S. D. Rosen, and L. A. Lasky. 1990. A homing receptor-IgG chimera as a probe for adhesive ligands of lymph node high endothelial venules. J. Cell Biol. 110:2221. 12. Hu, M. C., D. T. Crowe, I. L. Weissman, and B. Holzmann. 1992. Cloning and expression of mouse integrin bp(b7): a functional role in Peyer’s patch-specific lymphocyte homing. Proc. Natl. Acad. Sci. USA 89:8254. 13. Hamann, A., D. Jablonski-Westrich, P. Jonas, and H. Thiele. 1991. Homing receptors reexamined: mouse LECAM-1 (MEL-14 antigen) is involved in lymphocyte migration into gut-associated lymphoid tissue. Eur. J. Immunol. 21:2925. 14. Bargatze, R. F., P. R. Streeter, and E. C. Butcher. 1990. Expression of low levels of peripheral lymph node-associated vascular addressin in mucosal lymphoid tissues: possible relevance to the dissemination of passaged AKR lymphomas. J. Cell Biochem. 42:219. 15. Bargatze, R. F., M. A. Jutila, and E. C. Butcher. 1995. Distinct roles of L-selectin and integrins a4b7 and LFA-1 in lymphocyte homing to Peyer’s patch-HEV in situ: the multistep hypothesis confirmed and refined. Immunity 3:99. 16. Wagner, N., J. Lohler, E. J. Kunkel, K. Ley, E. Leung, G. Krissansen, K. Rajewsky, and W. Mu¨ller. 1996. Critical role for b7 integrins in formation of the gut-associated lymphoid tissue. Nature 382:366. 17. Sriramarao, P., U. H. von Andrian, E. C. Butcher, M. A. Burdon, and D. H. Broide. 1994. L-selectin and very late antigen-4 integrin promote eosinophil rolling at physiological shear rates in vivo. J. Immunol. 153:4238. 18. Berlin, C., R. F. Bargatze, J. J. Campbell, U. H. von Andrian, M. C. Szabo, S. R. Hasslen, R. D. Nelson, E. L. Berg, S. L. Erlandsen, and E. C. Butcher. 1995. a4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell 80:413. 19. Alon, R., P. D. Kassner, M. C. Carr, E. B. Finger, M. E. Hemler, and T. A. Springer. 1995. The integrin VLA-4 supports tethering and rolling in flow on VCAM-1. J. Cell Biol. 128:1243. 20. Xu, J., I. S. Grewal, G. P. Geba, and R. A. Flavell. 1996. Impaired primary T cell responses in L-selectin-deficient mice. J. Exp. Med. 183:589. 21. Catalina, M. D., M. C. Carroll, H. Arizpe, A. Takashima, P. Estess, and M. H. Siegelman. 1996. The route of antigen entry determines the requirement for L-selectin during immune responses. J. Exp. Med. 184:2341. 22. Steeber, D. A., N. E. Green, S. Sato, and T. F. Tedder. 1996. Lymphocyte migration in L-selectin-deficient mice: altered subset migration and aging of the immune system. J. Immunol. 157:1096. 23. Tang, M. L. K., L. P. Hale, D. A. Steeber, and T. F. Tedder. 1997. L-selectin is involved in lymphocyte migration to sites of inflammation in the skin: delayed rejection of allografts in L-selectin-deficient mice. J. Immunol. 158:5191. 24. Tedder, T. F., D. A. Steeber, and P. Pizcueta. 1995. L-selectin deficient mice have impaired leukocyte recruitment into inflammatory sites. J. Exp. Med. 181:2259. 25. Steeber, D. A., N. E. Green, S. Sato, and T. F. Tedder. 1996. Humoral immune responses in L-selectin-deficient mice. J. Immunol. 157:4899.
The Journal of Immunology 26. Steeber, D. A., M. A. Campbell, A. Basit, K. Ley, and T. F. Tedder. 1998. Optimal selectin-mediated rolling of leukocytes during inflammation in vivo requires intercellular adhesion molecule-1 expression. Proc. Natl. Acad. Sci. USA 95:7562. 27. Tang, M. L. K., D. A. Steeber, X.-Q. Zhang, and T. F. Tedder. 1998. Intrinsic differences in L-selectin expression levels affect T and B lymphocyte subsetspecific recirculation pathways. J. Immunol. 160:5113. 28. Holzmann, B., and I. L. Weissman. 1989. Peyer’s patch-specific lymphocyte homing receptors consist of a VLA-4-like a chain associated with either of two integrin b chains, one of which is novel. EMBO J. 8:1735. 29. Parker, C. M., K. L. Cepek, G. J. Russell, S. K. Shaw, D. N. Posnett, R. Schwarting, and M. B. Brenner. 1992. A family of b7 integrins on human mucosal lymphocytes. Proc. Natl. Acad. Sci. USA 89:1924. 30. Cepek, K. L., C. M. Parker, J. L. Madara, and M. B. Brenner. 1993. Integrin aEb7 mediates adhesion of T lymphocytes to epithelial cells. J. Immunol. 150:3459. 31. Cerf-Bensussan, N., A. Jarry, N. Brousse, B. Lisowska-Grospierre, D. Guy-Grand, and C. Griscelli. 1987. A monoclonal antibody (HML-1) defining a novel membrane molecule present on human intestinal lymphocytes. Eur. J. Immunol. 17:1279. 32. Cerf-Bensussan, N., B. Begue, J. Gagnon, and T. Meo. 1992. The human intraepithelial lymphocyte marker HML-1 is an integrin consisting of a b7 subunit associated with a distinctive a chain. Eur. J. Immunol. 22:273. 33. Erle, D. J. 1995. Intraepithelial lymphocytes: scratching the surface. Curr. Biol. 5:252. 34. Streeter, P. R., E. L. Berg, B. N. Rouse, R. F. Bargatze, and E. C. Butcher. 1988. A tissue-specific endothelial cell molecule involved in lymphocyte homing. Nature 331:41. 35. Nakache, M., E. Berg, P. Streeter, and E. Butcher. 1989. The mucosal vascular addressin is a tissue-specific endothelial cell adhesion molecule for circulating lymphocytes. Nature 337:179. 36. Briskin, M. J., L. M. McEvoy, and E. C. Butcher. 1993. MAdCAM-1 has homology to immunoglobulin and mucin-like adhesion receptors and to IgA1. Nature 363:461. 37. Szabo, M. C., E. C. Butcher, and L. M. McEvoy. 1997. Specialization of mucosal follicular dendritic cells revealed by mucosal addressin-cell adhesion molecule-1 display. J. Immunol. 158:5584. 38. Streeter, P. R., B. T. N. Rouse, and E. C. Butcher. 1988. Immunologic and functional characterization of a vascular addressin involved in lymphocyte homing into peripheral lymph nodes. J. Cell Biol. 107:1853. 39. Viney, J. L., S. Jones, H. H. Chiu, B. Lagrimas, M. E. Renz, L. G. Presta, D. Jackson, K. J. Hillan, S. Lew, and S. Fong. 1996. Mucosal addressin cell
6647
40.
41.
42.
43.
44.
45.
46.
47.
48.
49. 50.
51.
adhesion molecule-1: a structural and functional analysis demarcates the integrin binding motif. J. Immunol. 157:2488. Kunkel, E. J., C. L. Ramos, D. A. Steeber, W. Mu¨ller, N. Wagner, T. F. Tedder, and K. Ley. 1998. The role of L-selectin, b7 integrins and P-selectin in leukocyte rolling and adhesion in high endothelial venules of peyer’s patches. J. Immunol. 161:2449. Westermann, J., Y. Nagahori, S. Walter, C. Heerwagen, M. Miyasaka, and R. Pabst. 1994. B and T lymphocytes subsets enter peripheral lymph nodes and Peyer’s patches without preference in vivo: no correlation occurs between their localization in different types of high endothelial venules and the expression of CD44, VLA-4, LFA-1, ICAM-1, CD2 or L-selectin. Eur. J. Immunol. 24:2312. Croitoru, K., and J. Bienenstock. 1994. Characteristics and function of mucosaassociated lymphoid tissue. In Handbook of Mucosal Immunology. P. L. Ogra, W. Strober, J. Mestecky, J. R. McGhee, M. E. Lamm, and J. Bienenstock, eds. Academic Press, San Diego, CA, p. 141. Wagner, N., J. Lo¨hler, T. F. Tedder, K. Rajewsky, W. Mu¨ller, and D. A. Steeber. 1998. L-selectin and b7 integrin synergistically mediate lymphocyte migration to mesenteric lymph nodes. Eur. J. Immunol. In press. Steeber, D. A., P. Engel, A. S. Miller, M. P. Sheetz, and T. F. Tedder. 1997. Ligation of L-selectin through conserved regions within the lectin domain activates signal transduction pathways and integrin function in human, mouse and rat leukocytes. J. Immunol. 159:952. Stamper Jr., H. B., and J. J. Woodruff. 1976. Lymphocyte homing into lymph nodes: in vitro demonstration of the selective affinity of recirculating lymphocytes for high-endothelial venules. J. Exp. Med. 144:828. Diacovo, T. G., M. D. Catalina, M. H. Siegelman, and U. H. von Andrian. 1998. Circulating activated platelets reconstitute lymphocyte homing and immunity in L-selectin-deficient mice. J. Exp. Med. 187:197. Diacovo, T. G., K. D. Puri, R. A. Warnock, T. A. Springer, and U. H. von Andrian. 1996. Platelet-mediated lymphocyte delivery to high endothelial venules. Science 273:252. Hamann, A., D. Jablonski-Westrich, A. Duijvestijn, E. C. Butcher, H. Baisch, R. Harder, and H.-G. Thiele. 1988. Evidence for an accessory role of LFA-1 in lymphocyte-high endothelium interaction during homing. J. Immunol. 140:693. Snider, D. 1998. Memory T cell entry into Peyer’s patches directed by a4b7 integrin, in vivo evidence or selective interpretation. Mucosal Immunol. 6:11. Abitorabi, M. A., C. R. Mackay, E. H. Jerome, O. Osorio, E. C. Butcher, and D. J. Erle. 1996. Differential expression of homing molecules on recirculating lymphocytes from sheep gut, peripheral, and lung lymph. J. Immunol. 156:3111. Westermann, J., and R. Pabst. 1992. Distribution of lymphocyte subsets and natural killer cells in the human body. Clin. Invest. 70:539.
